Charles Shiner

Company: Beren Therapeutics

Job title: Vice President, Marketing

Bio:

Charlie Shiner is currently an associate vice-president at Rocket Pharmaceuticals; a gene therapy company focused on rare pediatric conditions. He has spent his last 15 years focused across large pharma and biotech companies for commercialization of therapies to treat rare disease affecting both pediatric and adult patients across nephrology, hematology, immunology and cardiology. His experience in supporting patient finding initiatives and the intersection of real-world data and partnerships is critical to ‘build the future’ for therapies in rare diseases.

Seminars:

Harnessing AI-Powered Patient Identification to Accelerate Trial Enrollment 11:00 am

Rapidly identifying eligible rare disease patients using AI to analyze medical records (EMR), claims databases, genetic testing partnerships and registries, cutting recruitment timelines by months Improving enrollment accuracy by targeting patients who precisely fit trial criteria (both interventional and natural history trials), lowering screen failure rates and cutting costs Enhancing recruitment efficiency with data-driven patient…Read more

day: Day One PM